FDA Inspection 1030355 — New England Baptist Hospital

New England Baptist Hospital — FEI 1270476

The FDA completed an inspection of New England Baptist Hospital on September 29, 2017 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 29, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)